Ligand Pharma (LGND) Tops Q2 EPS by 24c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. AWK
9. ACN
10. USO

Go back to Ligand Pharma (LGND) Tops Q2 EPS by 24c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus
LIGAND PHARMA (NASDAQ: LGND) Delayed: 279.44 +17.27 (6.59%)
Previous Close $262.17    52 Week High $139.79 
Open $259.35    52 Week Low $82.07 
Day High $282.53    P/E 649.86 
Day Low $258.00    EPS $0.43 
Volume 2,347,182